The 23-valent pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis: a double-blinded, randomized, placebo-controlled trial

BACKGROUND: Pneumococcal pneumonia is the most frequent form of pneumonia. We herein assessed the effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) in the prevention of pneumonia overall in rheumatoid arthritis (RA) patients at risk for infections. We hypothesized that PPSV...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Arthritis Res Ther
Päätekijät: Izumi, Yasumori, Akazawa, Manabu, Akeda, Yukihiro, Tohma, Shigeto, Hirano, Fuminori, Ideguchi, Haruko, Matsumura, Ryutaro, Miyamura, Tomoya, Mori, Shunsuke, Fukui, Takahiro, Iwanaga, Nozomi, Jiuchi, Yuka, Kozuru, Hideko, Tsutani, Hiroshi, Saisyo, Kouichirou, Sugiyama, Takao, Suenaga, Yasuo, Okada, Yasumasa, Katayama, Masao, Ichikawa, Kenji, Furukawa, Hiroshi, Kawakami, Kenji, Oishi, Kazunori, Migita, Kiyoshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5264490/
https://ncbi.nlm.nih.gov/pubmed/28122642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1207-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia